The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reaction Since Nationwide Launch

被引：0

作者：

Barrow, P. L. ^{[1
]}

Foy, M. ^{[1
]}

Gandhi, S. ^{[1
]}

O'Keefe, V. ^{[1
]}

King, C. ^{[1
]}

Webb, R. ^{[1
]}

机构：

[1] Med & Healthcare Prod Regulatory Agcy MHRA, Vigilance & Risk Management Med, Pharmacovigilance Signal Management Grp, London, England

来源：

DRUG SAFETY | 2009年 / 32卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

221

引用

页码：968 / 968

页数：1

共 50 条

[1] The Yellow Card Scheme: Experience of Patient Reporting of Adverse Drug Reactions 5 Years Since Launch
Cumber, Sarah L.
Heffer, Sarah J.
Gandhi, Shelley
Avery, Anthony J.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S321 - S321
[2] The yellow card scheme: Evaluation of patient reporting of suspected adverse drug reactions
Ekins-Daukes, S.
Irvine, D.
Wise, L.
Fiddes, S.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S105 - S105
[3] The Yellow Card Scheme: Patient Reporting of Adverse Drug Reactions and Signals they have Generated
Foy, M.
Gandhi, S.
Suri, S.
Cumber, S.
Jadeja, M. M.
[J]. DRUG SAFETY, 2011, 34 (10) : 903 - 903
[4] Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK
McLernon, David J.
Bond, Christine M.
Lee, Amanda J.
Watson, Margaret C.
Hannaford, Philip C.
Fortnum, Heather
Krska, Janet
Anderson, Claire
Murphy, Elizabeth
Avery, Anthony
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (05) : 523 - 531
[5] Patient reporting in Yellow Card scheme on the increase
[J]. Reactions Weekly, 2009, 1241 (1) : 1 - 1
[6] Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator
Deslandes, Paul N.
Bracchi, Robert
Jones, Karen
Haines, Kath E.
Carey, Emma
Adams, Alana
Walker, Jenna
Thomas, Alison
Routledge, Philip A.
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3829 - 3836
[7] The Yellow Card Scheme for reporting adverse drug reactions (ADRs) by patients in the UK will complement, not replace, the Yellow Card reports
[J]. Reactions Weekly, 2006, 1109 (1) : 3 - 3
[8] A BRIEF REVIEW OF THE YELLOW CARD ADVERSE REACTION REPORTING SCHEME IN THE UNITED-KINGDOM
BURTON, GH
MANN, RD
[J]. PHARMACOEPIDEMIOLOGY, VOL 1, 1989, : 121 - 132
[9] How Patient Reporters Identify Adverse Drug ReactionsA Qualitative Study of Reporting via the UK Yellow Card Scheme
Janet Krska
Claire Anderson
Elizabeth Murphy
Anthony J. Avery
[J]. Drug Safety, 2011, 34 : 429 - 436
[10] How Patient Reporters Identify Adverse Drug Reactions A Qualitative Study of Reporting via the UK Yellow Card Scheme
Krska, Janet
Anderson, Claire
Murphy, Elizabeth
Avery, Anthony J.
[J]. DRUG SAFETY, 2011, 34 (05) : 429 - 436

← 1 2 3 4 5 →